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Background
Dilated cardiomyopathy (DCM) is associated with a 20%
5 year mortality rate.
We identified that the presence of left ventricular (LV)
midwall fibrosis, detected by CMR late gadolinium
enhancement (LGE), was associated with a 5 fold
increased risk of cardiovascular death and adverse events,
independently of established predictors of outcome.
The natural course of DCM is however variable; up to
15% of patients may recover function, with normalisation
of left ventricular ejection fraction (LVEF).
We sought to evaluate whether LGE, a robust predictor
of clinical outcome, was predictive of remodelling in DCM.
Methods
130 prospectively recruited patients with DCM (mean
age 53.9 years, 65% male) underwent baseline and follow
up CMR studies using a 1.5T Siemens scanner.
The presence of midwall fibrosis was evaluated through
the administration of 0.1 mmol/kg of gadolinium based
contrast agent (Gadavist, Schering AG, Berlin). Images
were obtained using an inversion-recovery prepared gra-
dient echo sequence in standard long and short axis
views, with inversion times optimised to null normal
myocardium. Images were repeated in two separate phase
encoding directions to exclude artefact.
ANCOVA was used to evaluate the significance of
LGE on predicting the follow up LVEF, controlling for
the baseline LVEF and other covariates. Students t-test
was used to compare LVEF between groups with and
without LGE. All statistical calculations were performed
using R.
Results
Median follow up interval was 2.7 years between scans
(IQR 1.4-4.7 years). Fifty patients (38%) had evidence of
LV midwall fibrosis at baseline. The mean baseline
LVEF in patients with LGE was 39.3% and 43.6% in
patients without LGE (p=0.05; Figure 1). The mean
interval change in LVEF in patients with LGE was 5.1%
and 4.8% in those without (p=0.9).
Controlling for baseline LVEF, initial analysis using
ANCOVA found that those patients with DCM and LGE
had a 1.6% lower follow up LVEF than those without, but
this was not significant (p=0.429, 95% confidence interval
-5.9% to 2.5%).
When the additional variables were also included in the
model (age, gender, ethnicity, LV and RV end diastolic
and end systolic indexed volumes, baseline RVEF, mitral
regurgitation, history of AF and hypertension, baseline
pulse rate and blood pressure, NYHA class, and medica-
tion use- diuretic, beta blocker, ACE inhibitor and aldos-
terone antagonist), the estimated effect of LGE was a 2%
lower follow up LVEF, but this was not significant
(p=0.444, 95% confidence interval -7.5% to 3.3%).
Conclusions
Whilst LGE is a robust predictor of adverse outcome in
DCM, in this cohort there was no evidence to suggest
that the presence of LGE predicted left ventricular
remodelling.
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These findings highlight that predictors of outcome
and remodelling in DCM are not interchangeable. Our
future work will explore these findings in a larger cohort
with a quantitative evaluation of midwall fibrosis and to
evaluate the relationship between reverse remodelling
and clinical outcome in DCM.
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Figure 1 Baseline and follow up left ventricular ejection fraction (LVEF) in DCM patients stratified by the baseline presence or
absence of midwall fibrosis. LGE- late gadolinium enhancement.
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